[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CN1235577C - Products using L-arginine as raw materials - Google Patents

Products using L-arginine as raw materials Download PDF

Info

Publication number
CN1235577C
CN1235577C CNB031090605A CN03109060A CN1235577C CN 1235577 C CN1235577 C CN 1235577C CN B031090605 A CNB031090605 A CN B031090605A CN 03109060 A CN03109060 A CN 03109060A CN 1235577 C CN1235577 C CN 1235577C
Authority
CN
China
Prior art keywords
arginine
raw materials
procyanidin
phosphatidylcholine
health product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB031090605A
Other languages
Chinese (zh)
Other versions
CN1444872A (en
Inventor
杜越新
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB031090605A priority Critical patent/CN1235577C/en
Publication of CN1444872A publication Critical patent/CN1444872A/en
Application granted granted Critical
Publication of CN1235577C publication Critical patent/CN1235577C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to a product with L-arginine as production raw materials. The product comprises 15 to 95% of L-arginine, 5 to 85% of at least one kind of catalysis enhancing agents and 0 to 20% of at least one kind of solid agents, wherein the catalysis enhancing agents are one kind of raw materials in phosphatidylcholine, procyanidin and aweto polysaccharide or a composition of any two kinds or three kinds of the raw materials; the solid agents are one kind of materials in modified starch and meal cellulose and a mixture of the modified starch and the meal cellulose; through the synergistic action of the phosphatidylcholine, the procyanidin, the aweto polysaccharide and the L-arginine, the functions of the L-arginine for reducing the blood fat, lowering the blood pressure, resisting atherosclerosis, treating hepatosis and nephrosis, enhancing the immunity, resisting aging, resisting oxidation and improving male and female sexual function are further exerted; the present invention has the effects of exciting the activity of the L-arginine, strengthening the effect of the L-arginine and enhancing the function and the action intensity of the L-arginine. The product can be made into tablets or powder or capsules or beverages or cake or granular fabaceous health care medicine or health care food.

Description

With the L-arginine is the health product of raw materials for production
Technical field
The present invention relates to a kind of to the edible back of mammal health product with health role, particularly a kind of arginic health product of L-that contain.
Background technology
The L-arginine is the nutrient substance that extract from comprise nuts such as Semen sojae atricolor, Semen arachidis hypogaeae, Semen Juglandis, Semen Armeniacae Amarum, Semen coryli heterophyllae, it confirms by modern science to mammiferous Nutrition, blood fat reducing, blood pressure lowering, atherosclerosis, treatment hepatopathy, nephropathy, enhancing immunity, and improve the man, women's function aspects all has beneficial effect.But take this refinement material merely, produce a desired effect, need large dose oral administration.At present, seeking the arginic best compatibility material of L-, make the L-arginine can both inspire activity when any dosage is taken, strengthen its effect, strengthen its function and action intensity, is the difficult problem that scientist waits to study.
Summary of the invention
The invention provides a kind of is the health product of raw materials for production with the L-arginine, how solve makes the L-arginine inspire activity, strengthen its effect, strengthen the technical problem of its function and action intensity, reach the purpose that strengthens human immunocompetence, defying age, antioxidation, prevents and cures diseases.
The present invention is the technical scheme of the health product of raw materials for production with the L-arginine, it is characterized in that: contain L-arginine and at least a catalytic intensification agent in the health product, the arginic content of L-is 15-95%, and the catalytic intensification agent accounts for 5-85%, solid agent 0-20%.
Above-mentioned catalytic intensification agent is that phosphatidylcholine, procyanidin or Cordyceps polysaccharide select one or two to three kinds of raw material combination thing.
Above-mentioned solid agent is that modified starch and dietary cellulose select one or mixture.
Said ratio is: L-arginine: 15-95%, phosphatidylcholine 1-50%, procyanidin 1-40%, Cordyceps polysaccharide 1-60%, solid agent 1-20%.
Above-mentioned L-arginine 15-95%, phosphatidylcholine 2-50%, procyanidin 3-35%.
Above-mentioned L-arginine 15-95%, Cordyceps polysaccharide 2-50%, procyanidin 3-35%.
Above-mentioned L-arginine 15-95%, phosphatidylcholine 1-45%, Cordyceps polysaccharide 1-40%.
Above-mentioned L-arginine 15-95%, phosphatidylcholine 5-85%.Above-mentioned L-arginine 15-95%, procyanidin 5-85%.
Above-mentioned L-arginine 15-95%, Cordyceps polysaccharide 5-85%.
Beneficial effect: the present invention by phosphatidylcholine, procyanidin and Cordyceps polysaccharide select one or mixture cooperate with L-is arginic, increased the supply of various enzymes such as nitric oxide, lipoxidase, NO-synthase, strengthened the effect of NO-synthase, quickened the transmission of nitric oxide in neurotransmitter, beyond thought synergism has taken place.Further the performance latter is in the effect of blood fat reducing, blood pressure lowering, atherosclerosis, treatment hepatopathy, nephropathy, enhancing immunity, defying age, aging resistance and improvement man, women's function aspects.Its key component L-arginine is nitric oxide production precursor, can increase intravital nitric oxide after taking, thereby reach above-mentioned effect.Phosphatidylcholine and procyanidin then can be strengthened the effect of nitricoxide synthase, thereby as a kind of catalytic intensification agent, increase nitric oxide production output quantity, strengthen the arginic effect of taking of L-.Cordyceps polysaccharide then itself promptly has above-mentioned functions, has quickened the transmission of nitric oxide in neurotransmitter, with the L-arginine from the same effect in different paths, thereby strengthen the effect of L-arginine aspect above-mentioned.
The L-arginine is a kind of semi-dispensable amino acid, and phosphatidylcholine, procyanidin and Cordyceps polysaccharide are some has exciting, strengthen the active material of L-arginine, play the catalytic intensification effect.L-arginine and its esters or bases be as one of raw material, by with phosphatidylcholine, procyanidin and Cordyceps polysaccharide select one or mixture cooperate, can have special nutrition or special treatment purposes.Can be used as the antidote and the liver function-promoter of ammonia intoxication hepatic coma, evident in efficacy to viral hepatitis, diseases such as intestinal ulcer, thrombosis, neurasthenia and male's azoospermia disease all there is therapeutic effect.In addition, arginine is a kind of important intermediate metabolites of organism ornithine cycle, is again the synthetic precursor substance of NO in the body.Clinical research shows, arginine mixes with phosphatidylcholine, procyanidin and Cordyceps polysaccharide, and oral, has resisting hypertension, anti peroxidation of lipid and improves the effect of hemorheology.Arginine also has the raising function of immune system, reduces effects such as postoperative infection complication, even effectively treats some cancer.
The present invention is the goods of raw material with the L-arginine, through with phosphatidylcholine, procyanidin and Cordyceps polysaccharide select one or mixture cooperate, strengthen the effect of nitricoxide synthase, increase nitric oxide production output quantity, quicken the transmission of nitric oxide in neurotransmitter, strengthened the arginic effect of taking of L-.Male, especially those people of a specified duration inadequately that erect that obstacle is arranged to sexual function.Therefore can promote blood flow to penis, make it more strong, can increase sperm number, can be used for treating male sterility.
The present invention is the goods of raw material with the L-arginine, warp and catalytic intensification agent, promptly with phosphatidylcholine, procyanidin and Cordyceps polysaccharide select one or mixture cooperate, the manufacturing of energy stimulating growth hormone, and growth hormone is fatty for eliminating, strong muscle is very useful, can increase muscle and reduce fat, impel patient and serious burn patient's wound to restore.
The present invention is the goods of raw material with the L-arginine, through with phosphatidylcholine, procyanidin and Cordyceps polysaccharide select one or mixture cooperates, the reinforcement nitricoxide synthase effect, increase nitric oxide production output quantity, can stimulate thymus, raise immunity.Thymus is the glandula that is positioned at the breastbone rear, the inside has stored important disease-resistant cell-T cell, can help the external infection of body resistance, can increase the quantity of T cell, make health more effectively keep out the detrimental microorganisms invasion, the natural killer cell line anticancer with the mankind's immunocyte co-manufactured human body can suppress the formation of multiple malignant tumor.The present invention is the goods of raw material with the L-arginine, through with phosphatidylcholine, procyanidin and Cordyceps polysaccharide select one or after mixture cooperates, caused the synergism that increases nitrogen oxide, increase and strengthened the precursor of the deutero-relaxing factor of skin, relaxing factor is that nitric oxide (NO) not only has intensive diastole effect, but also can suppress that PA is assembled, anti-mononuclear cell depends on chemotactic, resisting vascular smooth muscle hyperplasia, these all are formed with crucial effect to tremulous pulse medicated porridge sample.Add strongly reducing blood fat, blood pressure lowering, atherosclerosis, treatment hepatopathy, nephropathy, enhancing immunity, reach the function of improving man, women's function aspects.
The specific embodiment
Goods of the present invention are one of raw material with the L-arginine, through with phosphatidylcholine, procyanidin and Cordyceps polysaccharide select one or mixture cooperate, some flavoring agents, modified starch, dietary fiber solid agent can be added, the health care medicine or the health food of tablet, powder, capsule, beverage, cake class or granule shape can be manufactured.
The L-arginine can be natural arginine or synthetic arginine, can refine from nut, seeds such as beans, Semen arachidis hypogaeae, Semen Juglandis, Semen Armeniacae Amarum, Semen coryli heterophyllae, Semen Helianthi, Fructus anacardii, adds gelatin and makes; The effect of phosphatidylcholine is confirmed by science that it can extract from raw materials such as Semen sojae atricolor; Procyanidin has antioxidant activity and eliminates the effect of free radical, can extract from seeds such as Semen Vitis viniferae; The medical value of Cordyceps polysaccharide is confirmed by motherland's medical science that it can extract from the Chinese medicine Cordyceps, also can replace with other saccharide and replace.
Below be several embodiments of the present invention:
L-arginine+phosphatidylcholine+procyanidin L-arginine+phosphatidylcholine+procyanidin+Cordyceps polysaccharide
15% + 50% + 35% 15% + 40% + 30% + 15%
20% + 47% + 33% 20% + 37% + 27% + 16%
25% + 44% + 31% 25% + 34% + 24% + 17%
30% + 41% + 29% 30% + 31% + 21% + 18%
35% + 38% + 27% 35% + 28% + 18% + 19%
40% + 35% + 25% 40% + 25% + 15% + 20%
45% + 32% + 23% 45% + 22% + 12% + 21%
50% + 29% + 21% 50% + 19% + 12% + 19%
55% + 26% + 19% 55% + 16% + 10% + 19%
60% + 23% + 17% 60% + 13% + 8% + 19%
65% + 20% + 15% 65% + 10% + 15% + 10%
70% + 17% + 13% 70% + 7% + 8% + 15%
75% + 14% + 11% 75% + 5% + 10% + 10%
80% + 11% + 9% 80% + 3% + 7% + 10%
85% + 8% + 7% 85% + 2% + 5% + 8%
90% + 5% + 5% 90% + 1% + 4% + 5%
95% + 2% + 3% 95% + 1% + 2% + 2%
L-arginine 15-95%, phosphatidylcholine 5-85%.
L-arginine 15-95%, procyanidin 5-85%.
L-arginine 15-95%, Cordyceps polysaccharide 5-85%.
L-arginine+phosphatidylcholine+solid agent L-arginine+procyanidin+solid agent
30% + 50% + 20% 40% + 40% + 20%
35% + 48% + 17% 45% + 40% + 15%
40% + 45% + 15% 50% + 34% + 16%
45% + 50% + 5% 55% + 30% + 15%
50% + 49% + 1% 60% + 35% + 5%
55% + 40% + 5% 65% + 25% + 10%
60% + 37% + 3% 70% + 23% + 7%
65% + 30% + 5% 75% + 20% + 5%
70% + 20% + 10% 80% + 15% + 5%
75% + 10% + 15% 85% + 3% + 12%
80% + 8% + 12% 90% + 9% + 1%
85% + 7% + 8% 95% + 4% + 1%
90% + 1% + 9%
95% + 4% + 1%
L-arginine+Cordyceps polysaccharide+solid agent L-arginine+Cordyceps polysaccharide+procyanidin
20% + 60%?+ 20% 15% + 50% + 35%
25% + 60% + 15% 20% + 45% + 35%
30% + 58% + 12% 25% + 45% + 30%
35% + 55% + 12% 30% + 40% + 30%
40% + 50% + 10% 35% + 40% + 25%
45% + 46% + 9% 40% + 33% + 27%
50% + 42% + 8% 45% + 30% + 25%
55% + 40% + 5% 50% + 30% + 20%
60% + 30% + 10% 55% + 25% + 20%
65% + 28% + 7% 60% + 23% + 17%
70% + 25% + 5% 65% + 20% + 15%
75% + 23% + 2% 70% + 5% + 25%
80% + 19% + 1% 75% + 10% + 15%
85% + 10% + 5% 80% + 15% + 5%
90% + 6% + 4% 85% + 5% + 10%
95% + 4% + 1% 90% + 5% + 5%
95% + 2% + 3%
L-arginine+phosphatidylcholine+Cordyceps polysaccharide
15% + 50% + 35%
20% + 47% + 33%
25% + 44% + 31%
30% + 41% + 29%
35% + 38% + 27%
40% + 35% + 25%
45% + 32% + 23%
50% + 29% + 21%
55% + 26% + 19%
60% + 23% + 17%
65% + 20% + 15%
70% + 17% + 13%
75% + 14% + 11%
80% + 11% + 9%
85% + 8% + 7%
90% + 5% + 5%
95% + 2% + 3%

Claims (9)

1, a kind of is the health product of raw materials for production with the L-arginine, it is characterized in that: contain L-arginine and at least a catalytic intensification agent in the health product, the arginic content of L-is 15-95%, and the catalytic intensification agent accounts for 5-85%, solid agent 0-20%;
Above-mentioned catalytic intensification agent is that phosphatidylcholine, procyanidin or Cordyceps polysaccharide select one or two to three kinds of raw material combination thing.
2, according to claim 1 is the health product of raw materials for production with the L-arginine, it is characterized in that: described solid agent is that modified starch and dietary cellulose select one or mixture.
3, according to claim 1 and 2 is the health product of raw materials for production with the L-arginine, and it is characterized in that: described proportioning is: L-arginine: 15-95%, phosphatidylcholine 1-50%, procyanidin 1-40%, Cordyceps polysaccharide 1-60%, solid agent 1-20%.
4, according to claim 1 is the health product of raw materials for production with the L-arginine, it is characterized in that: described L-arginine 15-95%, phosphatidylcholine 2-50%, procyanidin 3-35%.
5, according to claim 1 is the health product of raw materials for production with the L-arginine, it is characterized in that: described L-arginine 15-95%, Cordyceps polysaccharide 2-50%, procyanidin 3-35%.
6, according to claim 1 is the health product of raw materials for production with the L-arginine, it is characterized in that: described L-arginine 15-95%, phosphatidylcholine 1-45%, Cordyceps polysaccharide 1-40%.
7, according to claim 1 is the health product of raw materials for production with the L-arginine, it is characterized in that: described L-arginine 15-95%, phosphatidylcholine 5-85%.
8, according to claim 1 is the health product of raw materials for production with the L-arginine, it is characterized in that: described L-arginine 15-95%, procyanidin 5-85%.
9, according to claim 1 is the health product of raw materials for production with the L-arginine, it is characterized in that: described L-arginine 15-95%, Cordyceps polysaccharide 5-85%.
CNB031090605A 2003-04-03 2003-04-03 Products using L-arginine as raw materials Expired - Fee Related CN1235577C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB031090605A CN1235577C (en) 2003-04-03 2003-04-03 Products using L-arginine as raw materials

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB031090605A CN1235577C (en) 2003-04-03 2003-04-03 Products using L-arginine as raw materials

Publications (2)

Publication Number Publication Date
CN1444872A CN1444872A (en) 2003-10-01
CN1235577C true CN1235577C (en) 2006-01-11

Family

ID=27814504

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB031090605A Expired - Fee Related CN1235577C (en) 2003-04-03 2003-04-03 Products using L-arginine as raw materials

Country Status (1)

Country Link
CN (1) CN1235577C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8945655B2 (en) 2007-07-10 2015-02-03 Conopco, Inc. Stable and consumable compositions
WO2017010487A1 (en) * 2015-07-13 2017-01-19 協和発酵バイオ株式会社 Tablets containing arginine at high concentration

Also Published As

Publication number Publication date
CN1444872A (en) 2003-10-01

Similar Documents

Publication Publication Date Title
CN1644077A (en) Plant additive premixed forage for aquatic culture and bait therefrom
CN1927383A (en) Compound recipe preparation for lowering oxidative stress rapidly and prepn. method therefor
CN106107463A (en) Super Quinoa Antifatigue milk tea processing technology
CN1292683C (en) Solid beverage capable of balancing diet nutrition
CN1194703C (en) Health-care food for protecting gastric mucosa and its preparing process
CN1535605A (en) Drink and food
CN1620920A (en) Composite fungi amylose nutrient
CN101062025A (en) Compound anget for reducing weight, fat, sugar, pressure and for preventing and treating osteoporosis
US20080124318A1 (en) Algae supplement and treatment method
CN100339023C (en) Embryonic egg health-care food, and its making method
CN1235577C (en) Products using L-arginine as raw materials
CN101077166A (en) Assorted fruit can
CN1292756C (en) Effervescence tablet preparation for replenishing nutritious elements to human being and its preparation method
CN1651088A (en) Effervescent preparation using alditol as functional ingredient
CN1927059A (en) Buccal tablets produced with peanut and red date, and method for making same
CN1864545A (en) Preparation of highland barley SOD an conditioning food containing highland barley SOD
KR20140065924A (en) Onion peel powder material by creating supplements
CN1895293A (en) Spirulina oral tablet for supplementing human-body nutrients and its preparation
CN1193769C (en) Health-care food with sobering function
CN1207055C (en) Preparation method of cordyceps biological activity multivitamin intensifying agent
CN1293831C (en) Effervescent solid beverage of amino acid chelated calcium and its prepn
CN1611249A (en) Antisenescent longevity powder
CN106722971A (en) Cultivate the spirulina fertilizer powder of rich selenium germanium health-care rice
CN103948591B (en) A kind of slimming agents
CN1261103C (en) Microbial drug material, its preparing method and usage

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee